Decentralization Science New Star: A Striking Genomic Project

Recently, a decentralized science (DeSci) project called GenomesDAO has attracted attention in the industry. This project has the support of well-known investment institutions and primarily focuses on the DeSci and DAO fields. Its native token $GENOME currently has a market capitalization of approximately $16 million and has been listed on multiple trading platforms.

DeSci: A New Paradigm for Scientific Research

Decentralization Science (DeSci) is an emerging field aimed at reshaping the financing, collaboration, and intellectual property protection of research projects through Web3 technology. Although it currently does not receive much attention domestically, users abroad have shown sustained interest and confidence in this field.

The main goals of DeSci include:

1. Innovate the financing and fund allocation mechanism for scientific research projects
2. Change the collaboration model of research projects
3. Utilize Decentralization storage technology to protect intellectual property

Although DeSci has gained recognition from some well-known institutions and industry leaders, it is still in a relatively early stage compared to other popular concepts. However, considering the potential revolutionary impact of DeSci on research methods, this field may see significant development in the future.

GenomesDAO: Empowering Users with Sovereignty Over Genetic Data

GenomesDAO was established in 2018 and is one of the pioneers in the DeSci field. It is a biotechnology DAO that provides a secure, decentralized, incentive-based genomic testing platform. In light of the recent genomic data leakage incident, the data security and privacy protection philosophy of GenomesDAO has become particularly important.

The core philosophy of the platform is to return the ownership and control of genomic testing data to the users. Unlike traditional models, GenomesDAO allows users to manage their data in their "on-chain treasury" and profit from it. This model achieves an organic combination of privacy protection, data sovereignty, and token incentives.

Operating Model: DNA "Mining"

The operational process of GenomesDAO is as follows:

1. Provide users with genetic testing services
2. Upload the detection data to the DNA database, where the user has exclusive access.
3. Third-party pharmaceutical companies can apply to use DNA data with platform tokens.
4. Users can decide whether to agree or not. If they agree, they will receive platform tokens as a reward.

Users need to purchase testing services and return samples after receiving the sample collection kit. Once the testing is completed, the data will be uploaded to the user's personal database. Users can choose whether to allow third-party companies to access their data in order to receive token rewards.

Token Economic Model

The native token $GENOME of GenomesDAO has multiple functions:

• As a payment medium for third-party companies to access data
• Users unlock payment tools for disease testing reports
• DAO governance token, which can be obtained through staking for voting rights and rewards.

Currently, the market capitalization of $GENOME is approximately 16.5 million USD, with a trading price around 0.0174 USD.

Future Outlook

From an investment perspective, GenomesDAO has the following advantages:

• Have available products and revenue models
• Promising project narratives
• The development team is working hard continuously.
• The market cap and trading volume are relatively low, not overly hyped.
• Gain support from well-known investment institutions

It is worth noting that although the DeSci field is developing slowly overall, the team at GenomesDAO is still actively pushing forward:

• Seek cooperation with governments and pharmaceutical companies to provide users with more data monetization opportunities
• Attract users from traditional gene testing companies through innovative strategies

In summary, $GENOME may become a potential investment target. However, investors need to be patient and may have to wait for the overall warming of the DeSci field. For interested investors, it is recommended to consider small purchases in the coming months and hold for at least a year before reassessing. Please note that all investment decisions should be based on personal research and risk tolerance.